消化器外科学レビュー 2013-'14

出版社: 総合医学社
著者:
発行日: 2013-06-04
分野: 臨床医学:外科  >  消化器外科学
ISBN: 9784883788576
電子書籍版: 2013-06-04 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

10,450 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

10,450 円(税込)

目次

  • 消化器外科学レビュー 2013-'14

    ―目次―

    I章 
     1.食道・胃疾患
     2.腸疾患
     3.肝疾患
     4.門脈・脾
     5.胆道疾患
     6.膵疾患
     7.TOPICS

    II章
     1.癌転移の分子機構
     2.癌の遺伝子診断・治療
     3.抗がん剤【消化管】
     4.抗がん剤【肝胆膵】
     5.外科侵襲と栄養管理
     6.感染症
     7.癌免疫細胞治療
     8.ロボット支援手術の現状と展望
     9.肝胆膵の画像診断

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I章

P.3 掲載の参考文献
1) 小山恒男, 若槻俊之, 友利彰寿 他 : 【食道癌の発育進展-初期浸潤の病態と診断】食道粘膜癌の初期浸潤像の診断 拡大内視鏡の立場から. 胃と腸 47 (9) : 1360-1368, 2012
2) 小山恒男, 門馬久美子, 幕内博康 他 : 【[必携] 内視鏡リファレンスブック 2012】食道 食道扁平上皮癌の拡大内視鏡診断 日本食道学会分類の紹介. 消化器内視鏡 24 (4) : 466-468, 2012
P.4 掲載の参考文献
3) Sharma P, Meining AR, Coron E et al : Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy : final results of an international multicenter, prospective, randomized, controlled trial. Gastrointestinal endoscopy 74 (3) : 465-472, 2011
4) Gaddam S, Mathur SC, Singh M et al : Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol 106 (11) : 1961-1969, 2011
5) Ishihara R, Inoue T, Hanaoka N et al : Autofluorescence imaging endoscopy for screening of esophageal squamous mucosal high-grade neoplasia : a phase II study. J Gastroenterol Hepatol 27 (1) : 86-90, 2012
6) Umeoka S, Okada T, Daido S et al : "Early esophageal rim enhancement" : A new sign of esophageal cancer on dynamic CT. Eur J Radiol 82 (3) : 459-463, 2013
7) Tixier F, Hatt M, Le Rest CC et al : Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 53 (5) : 693-700, 2012
8) Aoyagi T, Shuto K, Okazumi S et al : Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surg 28 (4) : 252-257, 2011
P.5 掲載の参考文献
9) 上里昌也, 赤井崇, 堀部大輔 他 : 食道内視鏡的粘膜下層剥離術におけるクリップ牽引法の有効性. 千葉医学雑誌 87 (6) : 237-243, 2011
10) Machida H, Tominaga K, Minamino H et al : Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. Endoscopy 44 (6) : 622-625, 2012
11) Bergman JJ, Zhang YM, He S et al : Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastro Endosc 74 (6) : 1181-1190, 2011
12) Ando N, Kato H, Igaki H et al : A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19 (1) : 68-74, 2012
13) Sjoquist KM, Burmeister BH, Smithers BM et al : Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma : an updated meta-analysis. Lancet Oncol 12 (7) : 681-692, 2011
14) Yokota T, Hatooka S, Ura T et al : Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer. Anticancer Res 31 (10) : 3535-3541, 2011
15) Ferri LE, Ades S, Alcindor T et al : Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma : a multicenter phase II trial. Ann Oncol 23 (6) : 1512-1517, 2012
P.6 掲載の参考文献
16) Tamura S, Imano M, Takiuchi H et al : Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403). Anticancer Res 32 (4) : 1403-1408, 2012
17) Eisterer W, DE Vries A, Kendler D et al : Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II study. Anticancer Res 31 (12) : 4407-4412, 2011
18) Adelstein DJ, Rodriguez CP, Rybicki LA et al : A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction. Invest New Drugs 30 (4) : 1684-1689, 2012
19) Tomblyn MB, Goldman BH, Thomas CR Jr et al : Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer : a phase-II study of the SWOG (S0414). J Thorac Oncol 7 (5) : 906-912, 2012
20) Schmitt JM, Sommers SR, Fisher W et al : Sunitinib plus paclitaxel in patients with advanced esophageal cancer : a phase II study from the Hoosier Oncology Group. J Thorac Oncol 7 (4) : 760-763, 2012
21) Hurt CN, Nixon LS, Griffiths GO et al : SCOPE1 : a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC cancer 11 : 466, 2011
22) Yuasa Y, Seike J, Yoshida T et al : Sentinel lymph node biopsy using intraoperative indocyanine green fluorescence imaging navigated with preoperative CT lymphography for superficial esophageal cancer. Ann Surg Oncol 19 (2) : 486-493, 2012
23) Dantoc M, Cox MR, Eslick GD : Evidence to support the use of minimally invasive esophagectomy for esophageal cancer : a meta-analysis. Arch Surg 147 (8) : 768-776, 2012
P.7 掲載の参考文献
24) Tsujimoto H, Takahata R, Nomura S et al : Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications. Surgery 151 (5) : 667-673, 2012
25) Kinjo Y, Kurita N, Nakamura F et al : Effectiveness of combined thoracoscopiclaparoscopic esophagectomy : comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc 26 (2) : 381-390, 2012
26) Cerfolio RJ, Bryant AS, Hawn MT : Technical aspects and early results of robotic esophagectomy with chest anastomosis. J Thorac Cardiovasc Surg 145 (1) : 90-96, 2013
27) Suda K, Ishida Y, Kawamura Y et al : Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position : technical report and short-term outcomes. World J Surg 36 (7) : 1608-1616, 2012
28) Kono K, Iinuma H, Akutsu Y et al : Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med 10 : 141, 2012
29) Ohki S, Shibata M, Gonda K et al : Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer. Oncol Rep 28 (2) : 453-458, 2012
30) Akutsu Y, Yasuda S, Nagata M et al : A phase I/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus. J Surg Oncol 105 (8) : 750-755, 2012
P.8 掲載の参考文献
1) Tsuboi K, Hoshino M, Sundaram A et al : Role of the lower esophageal sphincter on esophageal acid exposure-a review of over 2000 patients. Trop Gastroenterol 33 : 107-111, 2012
2) Chan WW, Haroian LR, Gyawali CP : Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc 25 : 2943-2949, 2011
P.9 掲載の参考文献
3) 日本内視鏡外科学会学術委員会 : 内視鏡外科手術に関するアンケート調査-第11回集計結果報告-. 日鏡外会誌 17 (5) : 571-694, 2012
4) Ma S, Qian B, Shang L et al : A meta-analysis comparing laparoscopic partial versus Nissen fundoplication. ANZ J Surg 82 (1-2) : 17-22, 2012
5) Broeders JA, Roks DJ, Jamieson GG et al : Five-year outcome after laparoscopic anterior partial versus Nissen fundoplication : four randomized trials. Ann Surg 255 (4) : 637-642, 2012
6) Broeders JA, Bredenoord AJ, Hazebroek EJ et al : Reflux and belching after 270 degree versus 360 degree laparoscopic posterior fundoplication. Ann Surg 255 : 59-65, 2012
7) Mucio M, Rojano M, Herrera JJ et al : Novel surgical concept in antireflux surgery : long-term outcomes comparing 3 different laparoscopic approaches. Surgery 151 : 84-93, 2012
P.10 掲載の参考文献
8) Aye RW, Swanstrom LL, Kapur S et al : A randomized multiinstitution comparison of the laparoscopic Nissen and Hill repairs. Ann Thorac Surg 94 : 951-957, 2012
9) Pfluke JM, Parker M, Bowers SP et al : Use of mesh for hiatal hernia repair : a survey of SAGES members. Surg Endosc 26 : 1843-1848, 2012
10) Yigit T, Coskun AK, Sinan H et al : Rectus abdominus fascial sheath usage for crural reinforcement during surgical management of GERD : preliminary report of a prospective randomized clinical trial. Surg Laparosc Endosc Percutan Tech 22 : 333-337, 2012
11) Jarral OA, Athanasiou T, Hanna GB et al : Is an intra-oesophageal bougie of use during Nissen fundoplication? Interact Cardiovasc Thorac Surg 14 : 828-833, 2012
13) Wilshire CL, Niebisch S, Watson TJ et al : Dysphagia postfundoplication : more commonly hiatal outflow resistance than poor esophageal body motility. Surgery 152 : 584-592, 2012
14) Juhasz A, Sundaram A, Hoshino M et al : Endoscopic assessment of failed fundoplication : a case for standardization. Surg Endosc 25 : 3761-3766, 2011
P.11 掲載の参考文献
15) Hoshino M, Srinivasan A, Mittal SK : High-resolution manometry patterns of lower esophageal sphincter complex in symptomatic post-fundoplication patients. J Gastrointest Surg 16 : 705-714, 2012
16) Juhasz A, Sundaram A, Hoshino M et al : Outcomes of surgical management of symptomatic large recurrent hiatus hernia. Surg Endosc 26 : 1501-1508, 2012
17) 日本食道学会 編 : "食道アカラシア取扱い規約 第4版", 金原出版, pp3-21, 2012
18) Muller M, Eckardt AJ, Gopel B et al : Clinical and manometric course of nonspecific esophageal motility disorders. Dig Dis Sci 57 : 683-689, 2012
19) Stefamidis D, Richardson W, Farrell TM et al : SAGES guidelines for the surgical treatment of esophageal achalasia. Surg Endosc 26 : 296-311, 2012
20) Katzka DA, Castell DO : Review article : an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Aliment Pharmacol Ther 34 : 832-839, 2011
21) Inoue H, Minami H, Kobayashi Y et al : Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42 : 265-271, 2010
P.12 掲載の参考文献
22) Swanstrom LL, Kurian A, Dunst CM et al : Long-Term Outcomes of an Endoscopic Myotomy for Achalasia : The POEM Procedure. Ann Surg 256 : 659-667, 2012
23) Mayo D, Griffiths EA, Khan OA et al : Does the addition of a fundoplication improve outcomes for patients undergoing laparoscopic Heller's cardiomyotomy? Int J Surg 10 : 301-304, 2012
24) Rawlings A, Soper NJ, Oelschlager B et al : Laparoscopic Dor versus Toupet fundoplication following Heller myotomy for achalasia : results of a multicenter, prospective, randomized-controlled trial. Surg Endosc 26 : 18-26, 2012
25) Carter JT, Nguyen D, Roll GR et al : Predictors of long-term outcome after laparoscopic esophagomyotomy and Dor fundoplication for achalasia. Arch Surg 146 : 1024-1028, 2011
26) Wuller C, Bessell JR, Watson DI : Chest pain before and after laparoscopic cardiomyotomy for achalasia. ANZ J Surg 81 : 590-594, 2011
27) Wang Z, Zheng Q, Jin Z : Meta-analysis of robot-assisted versus conventional laparoscopic Nissen fundoplication for gastro-oesophageal reflux disease. ANZ J Surg 82 : 112-117, 2012
P.13 掲載の参考文献
28) Shaligram A, Unnirevi J, Simorov A et al : How does the robot affect outcomes? A retrospective review of open, laparoscopic, and robotic Heller myotomy for achalasia. Surg Endosc 26 : 1047-50, 2012,
29) Frazzoni M, Conigliaro R, Colli G et al : Conventional versus robot-assisted laparoscopic Nissen fundoplication : a comparison of postoperative acid reflux parameters. Surg Endosc 26 : 1675-1681, 2012
30) Storz P, Buess GF, Kunert W et al : 3D HD versus 2D HD : surgical task efficiency in standardised phantom tasks. Surg Endosc 26 : 1454-1460, 2012
P.14 掲載の参考文献
1) Jiang X, Hiki N, Nunobe S et al : Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107 : 275-279, 2012
2) Han DS, Suh YS, Kong SH et al : Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol 30 : 3834-3840, 2012
3) Ahn HS, Shin YS, Park PJ et al : Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer 106 : 733-739, 2012
P.15 掲載の参考文献
4) Terashima M, Kitada K, Ochiai A et al : Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res 18 : 5992-6000, 2012
5) Kim HI, Hyung WJ, Song KJ et al : Oral vitamin B12 replacement : an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol 18 : 3711-3717, 2011
6) Kim JW, Cheong JH, Hyung WJ et al : Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol 18 : 49-54, 2012
P.16 掲載の参考文献
7) Vinuela EF, Gonen M, Brennan MF et al : Laparoscopic versus open distal gastrectomy for gastric cancer : a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg 255 : 446-456, 2012
8) Gordon AC, Kojima K, Inokuchi M et al : Long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer. Surg Endosc 27 : 462-470, 2013
9) Park do J, Han SU, Hyung WJ et al : Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer : a large-scale multicenter retrospective study. Surg Endosc 26 : 1548-1553, 2012
10) Kanaya S, Kawamura Y, Kawada H et al : The delta-shaped anastomosis in laparoscopic distal gastrectomy : analysis of the initial 100 consecutive procedures of intracorporeal gastroduodenostomy. Gastric Cancer 14 : 365-371, 2011
11) Imamura H, Takiguchi S, Yamamoto K et al : Morbidity and mortality results from a prospective randomized controlled trial comparing Billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer. World J Surg 36 : 632-637, 2012
12) Takiguchi S, Yamamoto K, Hirao M et al : A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer : results from a multi-institutional RCT. Gastric Cancer 15 : 198-205, 2012
P.17 掲載の参考文献
13) Lee MS, Ahn SH, Lee JH et al : What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc 26 : 1539-1547, 2012
14) Nagasako Y, Satoh S, Isogaki J et al : Impact of anastomotic complications on outcome after laparoscopic gastrectomy for early gastric cancer. Br J Surg 99 : 849-854, 2012
15) Woo Y, Hyung WJ, Pak KH et al : Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg 146 : 1086-1092, 2011
16) Park SS, Kim MC, Park MS et al : Rapid adaptation of robotic gastrectomy for gastric cancer by experienced laparoscopic surgeons. Surg Endosc 26 : 60-67, 2012
17) Nunobe S, Hiki N, Gotoda T et al : Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer. Gastric Cancer 15 : 338-342, 2012
P.18 掲載の参考文献
18) Fujita J, Kurokawa Y, Sugimoto T et al : Survival benefit of bursectomy in patients with resectable gastric cancer : interim analysis results of a randomized controlled trial. Gastric Cancer 15 : 42-48, 2012
19) Chang YR, Han DS, Kong SH, et al : The value of palliative gastrectomy in gastric cancer with distant metastasis. Ann Surg Oncol 19 : 1231-1239, 2012
20) Chang JS, Lim JS, Noh SH et al : Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer : implications for postoperative radiotherapy. Radiother Oncol 104 : 367-373, 2012
P.19 掲載の参考文献
21) An JY, Kim KM, Kim YM et al : Surgical complications in gastric cancer patients preoperatively treated with chemotherapy : their risk factors and clinical relevance. Ann Surg Oncol 19 : 2452-2458, 2012
22) Fujiwara Y, Takiguchi S, Nakajima K et al : Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Ann Surg Oncol 18 : 3726-3731, 2011
23) Sasako M, Sakuramoto S, Katai H et al : Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29 : 4387-4393, 2011
24) Bang YJ, Kim YW, Yang HK et al : Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC) : a phase 3 open-label, randomised controlled trial. Lancet 379 : 315-321, 2012
P.20 掲載の参考文献
1) Musumba C, Jorgensen A, Sutton L et al : The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease : observation from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther 36 : 48-56, 2012
2) Laine L, Kivitz AJ, Bello AE et al : Double-blind randomized trials of singletablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers. Am J Gastroenterol 107 : 379-386, 2012
P.21 掲載の参考文献
3) Sugano K, Kontani T, Katsuo S et al : Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy : results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trail. J Gastroenterol 47 : 540-552, 2012
4) Sanuki T, Fujita T, Kutsumi H et al : Rabeprazole reduce the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease : a prospective randomized active-controlled trial. J Gastroenterol 47 : 1186-1197, 2012
5) Tanikawa C, Urabe Y, Matsuo K et al : A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet 44 : 430-434, 2012
6) Schottker B, Adamu MA, Weck MN et al : Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study. Clin Gastroenterol Hepatol 10 : 487-493, 2012
P.22 掲載の参考文献
7) Gisbert JP, Calvet X, Cosme A et al : Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Am J Gastroenterol 107 : 1197-1204, 2012
8) Sereni G, Azzolini F, Camellini L et al : Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World J Gastroenterol 18 : 4542-4548, 2012
9) McNicholl AG, Linares PM, Nyssen OP et al : Meta-analysis : esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 36 : 414-425, 2012
10) Federico A, Nardone G, Gravina AG et al : Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology 143 : 55-61, 2012
P.23 掲載の参考文献
11) Maehata Y, Nakamura S, Fujisawa K et al : Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 75 : 39-46, 2012
12) Nakamura S, Sugiyama T, Matsumoto T et al : Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori : a multicentre cohort follow-up study of 420 patients in Japan. Gut 61 : 507-513, 2012
13) Garcia-Iglesias P, Villoria A, Suarez D et al : Meta-analysis : predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther 34 : 888-900, 2011
14) Ljubicic N, Budimir I, Biscanin A et al : Endoclips vs large or small-volume epinephrine in peptic ulcer recurrent bleeding. World J Gastroenterol 18 : 2219-2224, 2012
15) Yen HH, Yang CW, Su PY et al : Use of hemostatic forceps as a preoperative rescue therapy for bleeding peptic ulcer. Surg Laparosc Endosc Percutan Tech 21 : 380-382, 2011
P.24 掲載の参考文献
16) Kuwabara K, Matsuda S, Fushimi K et al : Community-based evaluation of laparoscopic versus open simple closure of perforated peptic ulcers. World J Surg 35 : 2485-2492, 2012
17) Moran EA, Gostout CJ, McConico AL et al : Assessing the invasiveness of NOTES perforated viscus repair : a comparative study of NOTES and laparoscopy. Surg Endosc 26 : 103-109, 2012
18) Bonin EA, Moran E, Gostout CJ et al : Natural orifice transluminal endoscopic surgery for patients with perforated peptic ulcer. Surg Endosc 26 : 1534-1538, 2012
19) Lagergren J, Lindam A, Mason RM : Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population-based study. Int J Cancer 131 : E1048-E1052, 2012
P.25 掲載の参考文献
1) D'Journo XB, Ouattara M, Loundou A et al : Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer. Dis Esophagus 25 : 527-534, 2012
2) Derogar M, Orsini N, Sadr-Azodi O et al : Influence of major post operative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol 30 : 1615-1619, 2012
P.26 掲載の参考文献
3) Nishimura K, Tanaka T, Tsubuku T et al : Reflux esophagitis after esophagectomy : impact of duodenogastroesophageal reflux. Dis Esophagus 25 : 381-385, 2012
4) Yano M, Motoori M, Tanaka K et al : Prevention of gastroduodenal content reflux and delayed gastric emptying after esophagectomy : gastric tube reconstruction with duodenal diversion plus Roux-en-Y anastomosis. Dis Esophagus 25 : 181-187, 2012
5) Miyazaki T, Tanaka N, Hirai H et al : Ghrelin level and body weight loss after esophagectomy for esophageal cancer. J Surg Res 176 : 74-78, 2012
6) Koizumi M, Hosoya Y, Dezaki K et al : Postoperative weight loss does not resolve after esophagectomy despite normal serum ghrelin levels. Ann Thorac Surg 91 : 1032-1037, 2012
7) Biere SS, van Berge Henegouwen MI et al : Minimally invasive versus open oesophagectomy for patients with oesophageal cancer : a multicentre, openlabel, randomised controlled trial. Lancet 379 : 1887-1892, 2012
8) Mamidanna R, Bottle A, Hanna GB : Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England : a population-based national study. Ann Surg 255 : 197-203, 2012
P.27 掲載の参考文献
9) Yamada E, Shirakawa Y, Yamatsuji T et al : Jejunal interposition reconstruction with a stomach preserving esophagectomy improves postoperative weight loss and reflux symptoms for esophageal cancer patients. J Surg Res 178 : 700-707, 2012
10) Sultan J, Griffin SM, Di Franco F et al : Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99 : 346-355, 2012
P.28 掲載の参考文献
11) Dikic S, Randjelovic T, Dragojevic S et al : Early dumping syndrome and reflux esophagitis prevention with pouch reconstruction. J Surg Res 175 : 56-61, 2012
12) Ahn SH, Lee JH, Park DJ : Comparative study of clinical outcomes between laparoscopy-assisted proximal gastrectomy (LAPG) and laparoscopy-assisted total gastrectomy (LATG) for proximal gastric cancer. Gastric Cancer epub (doi : 10.1007/s10120-012-0178-x, 2012)
13) Katai H, Morita S, Saka M et al : Long-term outcome after proximal gastrectomy with jejunal interposition for suspected early cancer in the upper third of the stomach. Br J Surg 97 : 558-562, 2012
14) Namikawa T, Oki T, Kitagawa H et al : Impact of jejunal pouch interposition reconstruction after proximal gastrectomy for early gastric cancer on quality of life : short- and long-term consequences. Am J Surg 204 : 203-209, 2012
15) Takiguchi S, Yamamoto K, Hirao M et al : A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer : results from a multi-institutional RCT. Gastric Cancer 15 : 198-205, 2012
P.29 掲載の参考文献
16) Inokuchi M, Kojima K, Yamada H et al : Long-term outcomes of Roux-en-Y and Billroth-I reconstruction after laparoscopic distal gastrectomy. Gastric Cancer 16 : 67-73, 2012
17) Lee MS, Ahn SH, Lee JH et al : What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc 26 (6) : 1539-1547, 2012
18) 杉山貢, 國崎主, 加藤広 他 : 胃切除後の骨代謝障害に対するアレンドロネートの有用性の検討. 日消外誌 44 : 361-373, 2012
19) Lim JS, Jin SH, Kim SB et al : Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy. J Clin Gastroenterol 46 : 669-674, 2012
20) Aoki T, Yamaji I, Hisamoto T et al : Irregular bowel movement in gastrectomized subjects : bowel habits, stool characteristics, fecal flora, and metabolites. Gastric Cancer 15 : 396-404, 2012
21) Tanaka K, Yano M, Motoori M et al : Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy : a prospective randomized controlled trial. Surgery 152 : 832-842, 2012
P.30 掲載の参考文献
22) Kim HI, Hyung WJ, Song KJ et al : Oral vitamin B12 replacement : an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol 18 : 3711-3717, 2012
P.31 掲載の参考文献
1) Buchwald H, William SE : Metabolic surgery worldwide 2003. Obes Surg 14 : 1157-1164, 2004
2) Buchwald H, Oien DM : Metabolic/bariatric surgery worldwide 2008. Obes Surg 19 : 1605-1611, 2009
4) Franco JV, Ruiz PA, Palermo M et al : A review studies comparing three laparoscopic procedures in bariatric surgery : sleeve gastrectomy, Roux-en-Y gastric bypass and adjustablegastric banding. Obes Surg 21 : 1458-1468, 2011
P.32 掲載の参考文献
5) 北野正剛, 山下裕一, 白石憲男 他 : 日本内視鏡外科学会 内視鏡外科手術に関するアンケート調査 第10回集計結果報告. 日本内視鏡外科学会雑誌 17 (5) : 591-694, 2012
6) http://plaza.umin.ac.jp/~jsto/gakujyutsu/updata/statement_2010.pdf
P.33 掲載の参考文献
7) Regan JP, Inabnet WB, Gagner M et al : Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13 : 861-864, 2003
8) Eid GM, Brethauer S, Mattar SG et al : Laparoscopic sleeve gastrectomy for super obese patients : forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. Ann Surg 256 : 262-265, 2012
9) Rosenthal RJ ; International Sleeve Gastrectomy Expert Panel : International sleeve gastrectomy expert panel consensus statement : best practice guidelines based on experience of > 12,000 cases. Surg Obes Relat Dis 8 : 8-19, 2012
10) Jimenez A, Casamitjana R, Flores L et al : ong term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 256 : 1023-1029, 2012
11) Kasama K, Mui W, Lee WJ et al : IFSOAPC consensus statements 2011. Obes Surg 22 : 677-684, 2012
P.34 掲載の参考文献
12) Schauer PR, Kashyap SR, Wolski K et al : Bariatric surgery versus intensive medical therapy in obese patients with diabetes. NEJM 366 : 1567-1576, 2012.
13) Mingrone G, Panunzi S, De Gaetano A et al : Bariatric surgery versus intensive medical therapy for type 2 diabetes. NEJM 366 : 1577-1585, 2012
14) Ohta M, Kitano S, Kasama K et al : Results of anational survey on laparoscopic bariatric surgery in Japan, 2000-2009. Asian J Endosc Surg 4 : 138-142, 2011
15) Lee WJ, Chong K, Ser KH et al : Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus : a randomized controlled trial. Arch Surg 146 : 143-148, 2011
16) Lee WJ, Hur KY, Lakadawala M et al : Predicting success of metabolic surgery : age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis Aug 6, 2012 (doi : 10.1016/j.soard.2012.07.015)
17) 山本寛, 谷徹 : 現在の肥満外科治療の問題点. 成人病と生活習慣病 40 (3) : 288-294, 2010
P.35 掲載の参考文献
1) Fox J, Gross CP, Longo W et al : Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum 55 : 501-508, 2012
2) Vaid S, Tucker J, Bell T et al : Cost analysis of laparoscopic versus open colectomy in patients with colon cancer : results from a large nationwide population database. Am Surg 78 : 635-641, 2012
3) Surgical care and Outcomes Assessment Program (SCOAP) Collaborative, Billingham R, et al : Adoption of laparoscopy for elective colorectal resection : a report from the Surgical Care and Outcomes Assessment Program. J Am Coll Surg 214 : 909-918, 2012
P.36 掲載の参考文献
4) She WH, Poon JT, Fan JK et al : Outcome of laparoscopic colectomy for cancer in elderly patients. Surg Endosc 27 : 308-312, 2012
5) Hida K, Hasegawa S, Kinjo Y et al : Open versus laparoscopic resection of primary tumor for incurable stage IV colorectal cancer : a large multicenter consecutive patients cohort study. Ann Surg 255 : 929-934, 2012
6) Kim SJ, Ryu GO, Choi BJ et al : The short-term outcomes of conventional and single-port laparoscopic surgery for colorectal cancer. Ann Surg 254 : 933-940, 2011
7) Makino T, Milsom JW, Lee SW : Feasibility and safety of single-incision laparoscopic colectomy : a systematic review. Ann Surg 255 : 667-676, 2012
8) Park JS, Choi GS, Park SY et al : Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg 99 : 1219-1226, 2012
P.37 掲載の参考文献
9) Aarts MA, Okrainec A, Glicksman A et al : Adoption of enhanced recovery after surgery (ERAS) strategies for colorectal surgery at academic teaching hospitals and impact on total length of hospital stay. Surg Endosc 26 : 442-450, 2012
10) http://www.mhlw.go.jp/stf/shingi/2r9852000001u23a.html http://hospia.jp/dpc/
11) Henderson S, Morris AM, Zhang W et al : Early discharge and hospital readmission after colectomy for cancer. Dis Colon Rectum 54 : 1362-1367, 2011
12) Shapiro R, Vogel JD, Kiran RP : Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery : an additional benefit of the minimally invasive approach? Dis Colon Rectum 54 : 1496-1502, 2011
13) Masoomi H, Kang CY, Chen A et al : Predictive factors of in-hospital mortality in colon and rectal surgery. J Am Coll Surg 215 : 255-261, 2012
P.38 掲載の参考文献
14) West NP, Kobayashi H, Takahashi K et al : Understanding optimal colonic cancer surgery : comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 30 : 1763-1769, 2012
15) Akiyoshi T, Watanabe T, Miyata S et al : Results of Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer : is it regional or distant disease? Ann Surg 255 : 1129-1134, 2012
16) McCahill LE, Yothers G, Sharif S et al : Primary mFOLFOX6 plus bevacizmab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer : definitive analysis of NSABP trial C-10. J Clin Oncol 30 : 3223-3228, 2012
P.39 掲載の参考文献
17) Abbott AM, Parsons HM, Tuttle TM et al : Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases : a population study. Ann Surg Oncol 20 : 139-147, 2013
18) Zhang Y, Shi J, Shi B et al : Self-expanding metallic stent sa a bridge to surgery versus emergency surgery for obstractive colorectal cancer : a meta-analysis. Surg Endosc 26 : 110-119, 2012
19) Lee WS, Baek JH, Kang JM et al : The outcome after stent placement or surgery as the initial treatment for obstructive primary tumor in patients with Stage IV colon cancer. Am J Surg 203 : 715-719, 2012
20) Parsons HM, Tuttle TM, Kunts KM et al : Association between lymphnode evaluation for colon cancer and node positivity over the past 20 years. JAMA 306 : 1089-1097, 2011
21) Sjo OH, Merok MA, Svindland A et al : Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 55 : 307-315, 2012
22) Van der Zaag ES, Bouma WH, Tanis PJ et al : Systemic review of sentinel lymph node mapping procedure in colorectal cancer. Ann Surg Oncol 19 : 3449-3459, 2012
P.40 掲載の参考文献
23) Yothers G, O'Connell MJ, Allegra DJ et al : Oxaliplatin as adjuvant therapy for colon cancer : updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29 : 3768-3774, 2011
24) Alberts SR, Sargent DJ, Nair S et al : Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer : a randomized trial. JAMA 307 : 1383-1393, 2012
25) Chang GJ, Kaiser AM, Mills S et al : Practice parameters for the management of colon cancer. Dis Colon Rectum 55 : 831-843, 2012
P.41 掲載の参考文献
1) Bonnetain F, Bosset JF, Gerard JP et al : What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials : surrogacy in question? Eur J Cancer 48 (12) : 1781-1790, 2012
2) Sauer R, Liersch T, Merkel S et al : Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer : results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30 (16) : 1926-1933, 2012
P.42 掲載の参考文献
3) Rodel C, Liersch T, Becker H et al : Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer : initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13 (7) : 679-687, 2012
4) Hofheinz RD, Wenz F, Post S et al : Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer : a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 13 (6) : 579-588, 2012
5) Dewdney A, Cunningham D, Tabernero J et al : Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol 30 (14) : 1620-1627, 2012
6) Marechal R, Vos B, Polus M et al : Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer : a randomized multicentric phase II study. Ann Oncol 23 (6) : 1525-1530, 2011
P.43 掲載の参考文献
7) Martin ST, Heneghan HM, Winter DC : Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 99 (7) : 918-928, 2012
8) Glynne-Jones R, Hughes R : Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg 99 (7) : 897-909, 2012
9) Maas M, Beets-Tan RG, Lambregts DM et al : Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29 (35) : 4633-4640, 2011
10) Perez RO, Habr-Gama A, Gama-Rodrigues J et al : Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation : long-term results of a prospective trial (National Clinical Trial 00254683). Cancer 118 (14) : 3501-3511, 2011
P.44 掲載の参考文献
11) Mezhir JJ, Shia J, Riedel E et al : Wholemount pathologic analysis of rectal cancer following neoadjuvant therapy : implications of margin status on long-term oncologic outcome. Ann Surg 256 (2) : 274-279, 2012
12) Govindarajan A, Gonen M, Weiser MR et al : Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol 29 (34) : 4568-4573, 2011
13) Smith FM, Chang KH, Sheahan K et al : The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy. Br J Surg 99 (7) : 993-1001, 2012
P.45 掲載の参考文献
14) Trastulli S, Farinella E, Cirocchi R et al : Robotic resection compared with laparoscopic rectal resection for cancer : systematic review and meta-analysis of short-term outcome. Colorectal Dis 14 (4) : e134-156, 2012
15) Kim JY, Kim NK, Lee KY et al : A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer : laparoscopic versus robotic surgery. Ann Surg Oncol 19 (8) : 2485-2493, 2012
16) West NP, Kobayashi H, Takahashi K et al : Understanding optimal colonic cancer surgery : comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 30 (15) : 1763-1769, 2012
P.46 掲載の参考文献
17) Fujita S, Akasu T, Mizusawa J et al : Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212) : results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 13 (6) : 616-621, 2012
18) Akiyoshi T, Watanabe T, Miyata S et al : Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer : is it regional or distant disease? Ann Surg 255 (6) : 1129-1134, 2012
19) Ding P, Liska D, Tang P et al : Pulmonary recurrence predominates after combined modality therapy for rectal cancer : an original retrospective study. Ann Surg 256 (1) : 111-116, 2012
P.47 掲載の参考文献
1) Malgras B, Soyer P, Boudaf M et al : Accuracy of imaging for predicting operative approach in Crohn's disease. Br J Surg 99 : 1011-1020,
P.48 掲載の参考文献
2) Nanda K, Courtney W, Keegan D et al : Prolonged avoidance of repeat surgery with endoscopic balloon dilatation of anastomotic strictures in Crohn's disease. J Crohns Colitis, 2012 (doi : 10.1016/j.crohns.2012.07.019)
3) Watanabe T, Sasaki I, Sugita A et al : Time trend and risk factors for reoperation in Crohn's disease in Japan. Hepatogastroenterology 59 (116) : 1081-1086, 2012
4) Lee KY, Yu CS, Lee KY et al : Risk factors for repeat abdominal surgery in Korean patients with Crohn's disease : a multi-center study of a Korean inflammatory bowel disease study group. J Korean Soc Coloproctol, 2012 (doi : 10.3393/jksc.2012.28.4.188)
5) Kanazawa A, Yamana T, Okamoto K et al : Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease. Dis Colon Rectum 55 : 957-962, 2012
6) Bellolio F, Cohen Z, MacRae HM et al : Strictureplasty in selected Crohn's disease patients results in acceptable long-term outcome. Dis Colon Rectum 55 : 864-869, 2012
7) Campbell L, Ambe R, Weaver J et al : Comparison of conventional and nonconventional strictureplasties in Crohn's disease : a systematic review and meta-analysis. Dis Colon Rectum 55 (6) : 714-726, 2012
P.49 掲載の参考文献
8) 内視鏡外科手術に関するアンケート調査-第11回集計結果報告-. 日内視鏡外科会誌 17 (5) : 607-611, 2012
9) Rijcken E, Mennigen R, Senninger N et al : Single-port laparoscopic surgery for inflammatory bowel disease. Minim Invasive Surg, 2012 (doi : 10.1155/2012/106878)
10) Hung R, Valerian BT, Lee EC : Laparoscopic approach in patients with recurrent Crohn's disease. Am Surg 78 : 595-599, 2012
11) Ehteshami-Afshar S, Nikfar S, Rezaie A et al : A systemic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci 7 (6) : 1000-1012, 2011
12) Waterman M, Xu W, Dinani A et al : Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut 62 (3) : 387-394, 2013
13) Papamichael K, Archavlis E, Lariou C et al : Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease : A prospective, two-year, single center, pilot study. J Crohns Colitis 6 : 924-931, 2012
14) Aguas M, Bastida G, Cerrillo E et al : Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J Gastroenterol 18 (32) : 4391-4398, 2012
15) Yoshida K, Fukunaga K, Ikeuchi H et al : Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection : A 3-year prospective randomized open trial. Inflamm Bowel Dis 18 (9) : 1617-1623, 2012
P.50 掲載の参考文献
16) Targownik LE, Singh H, Nugent Z et al : The epidemiology of colectomy in ulcerative colitis : results from a population-based cohort. Am J Gastroenterol 107 (8) : 1228-1235, 2012
17) 内野基, 池内浩基, 竹末芳生 他 : 潰瘍性大腸炎手術におけるSSIの検討. 日本腹部救急会誌 32 (6) : 1033-1039, 2012
18) Nisar PJ, Appau KA, Remzi FH et al : Preoperative hypoalbuminemia is associated with adverse outcomes after ileoanal pouch surgery. Inflamm Bowel Dis 18 (6) : 1034-1041, 2012
19) Powar MP, Martin P, Croft AR et al : Surgical outcomes in steroid refractory acute severe ulcerative colitis : The impact of rescue therapy. Colorectal Dis, 2012 (doi : 10.111/j.1463-1318.2012.03188.x.)
20) Kiely JM, Fazio VW, Remzi FH et al : Pelvic sepsis after IPAA adversely function of the pouch and quality of life. Dis Colon Rectum 55 (4) : 387-392, 2012
P.51 掲載の参考文献
21) Merrill A, Millham F : Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease : a study of National Surgical Quality Improvement Program patients. Arch Surg 147 (2) : 120-124, 2012
22) Miller AT, Berian JR, Rubin M et al : Robotic-assisted proctectomy for inflammatory bowel disease : a case-matched comparison of laparoscopic and robotic technique. J Gastrountest Surg 16 (3) : 587-594, 2012
23) Suzuki H, Ogawa H, Shibata C et al : The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum 55 : 330-336, 2012
24) 杉田昭, 池内浩基, 舟山裕士 他 : 潰瘍性大腸炎手術例の術後長期経過の検討-多施設共同研究による術後5年以上経過例の分析-. 日消誌 108 : 1996-2002, 2011
25) 河俣あゆみ, 内田恵一, 井上幹大 : 小児炎症性腸疾患で外科治療を受けた子どもに対するQOL評価-潰瘍性大腸炎で大腸全摘手術を受けた子供のQOL-. 小児保健研究 71 (5) : 731-736, 2012
P.52 掲載の参考文献
26) Kuruvilla K, Osler T, Hyman NH : A Comparison of the quality of life of ulcerative colitis patients after IPAA vs ileostomy. Dis Colon Rectum 55 : 1131-1137, 2012
P.53 掲載の参考文献
1) Ben Q, An W, Jiang Y et al : Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142 : 762-772, 2012
2) 佐藤友美, 野崎良一, 山田一隆 他 : 肥満と大腸腺腫発生部位との関連性. 人間ドック 26 (5) : 734-742, 2012
P.54 掲載の参考文献
3) Manser CN, Bachmann LM, Brunner J et al : Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death : a closed cohort study. Gastrointest Endosc 76 : 110-117, 2012
5) Brenner H, Chang-Claude J, Rickert A et al : Risk of colorectal cancer after detection and removal of adenomas at colonoscopy : population-based casecontrol study. J Clin Oncol 30 : 2969-2976, 2012
6) Ikematsu H, Saito Y, Tanaka S et al : The impact of narrow band imaging for colon polyp detection : a multicenter randomized controlled trial by tandem colonoscopy. J Gastroenterol 47 : 1099-1107, 2012
P.55 掲載の参考文献
7) Jin XF, Chai TH, Shi JW et al : Meta-analysis for evaluating the accuracy of endoscopy with narrow band imaging in detecting colorectal adenomas. J Gastroenterol Hepatol 27 : 882-887, 2012
8) Leufkens AM, van Oijen MG, Vleggaar FP et al : Factors influencing the miss rate of polyps in a back-to-back colonoscopy study. Endoscopy 44 : 470-475, 2012
9) Chiu HM, Lin JT, Lee YC et al : Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population. Dis Colon Rectum 54 : 1570-1577, 2011
10) Peng J, He Y, Xu J et al : Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans : results of a prospective study. Colorectal Dis 13 : e374-378, 2011
11) Hirakawa T, Kato J, Okumura Y et al : Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT). J Gastroenterol 47 : 127-135, 2012
12) Zalis ME, Blake MA, Cai W et al : Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults : a prospective evaluation. Ann Intern Med 156 : 692-702, 2012
P.56 掲載の参考文献
13) 中澤三郎, 乾和郎, 服部外志之 他 : CT colonographyの臨床的研究. 日本消化器がん検診学会雑誌 49 (6) : 1105-1113, 2011
14) Pohl H, Srivastava A, Bensen SP et al : Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 144 : 74-80, 2013
15) Burnett-Hartman AN, Newcomb PA, Phipps AI et al : Colorectal endoscopy, advanced adenomas, and sessile serrated polyps : implications for proximal colon cancer. Am J Gastroenterol 107 : 1213-1219, 2012
P.57 掲載の参考文献
16) Kobayashi N, Yoshitake N, Hirahara Y et al : Matched case-control study comparing endoscopic submucosal dissection and endoscopic mucosal resection for colorectal tumors. J Gastroenterol Hepatol 27 : 728-733, 2012
17) Terasaki M, Tanaka S, Oka S et al : Clinical outcomes of endoscopic submucosal dissection and endoscopic mucosal resection for laterally spreading tumors larger than 20 mm. J Gastroenterol Hepatol 27 : 734-740, 2012
18) Alderlieste YA, Rauws EA, Mathus-Vliegen EM et al : Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis. Fam Cancer 12 : 51-56, 2013
19) Bulow S, Christensen IJ, Hojen H et al : Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis 14 : 947-952, 2012
P.58 掲載の参考文献
20) Bartels SA, D'hoore A, Cuesta MA et al : Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy : a cross-sectional study. Ann Surg 256 : 1045-1048, 2012
21) Tonelli F, Ficari F, Bargellini T et al : Ileal pouch adenomas and carcinomas after restorative proctocolectomy for familial adenomatous polyposis. Dis Colon Rectum 55 : 322-329, 2012
22) Banasiewicz T, Marciniak R, Kaczmarek E et al : The prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP. Int J Colorectal Dis 26 : 1197-1203, 2011
23) Pioche M, Aguero Garcete G, Forestier J et al : Macroscopic and histologic regression of duodenal polyposis with FOLFOX4 chemotherapy for an ileal pouch adenocarcinoma in a patient with familial adenomatous polyposis. Endoscopy 44 : 1165-1167, 2012
P.59 掲載の参考文献
1) 大腸癌研究会 編 : リンチ症候群. "遺伝性大腸癌診療ガイドライン", 金原出版, pp31-73, 2012
P.60 掲載の参考文献
2) Steinhagen E, Shia J, Markowitz AJ et al : Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resection. J Am Coll Surg 214 : 61-67, 2012
3) van Lier MG, Leenen CH, Wagner A et al ; LIMO Study Group : Yield of routine molecular analyses in colorectal cancer patients <- 70 years to detect underlying Lynch syndrome. J Pathol 226 : 764-774, 2012
4) Warrier SK, Trainer AH, Lynch AC et al : Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis Colon Rectum 54 : 1480-1487, 2011
5) Weissman SM, Burt R, Church J et al : Identification of individuals at risk for Lynch syndromeu sing targeted evaluations and genetic testing : National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Counsel 21 : 484-493, 2012
P.61 掲載の参考文献
6) Chubak B, Heald B, Sharp RR : Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome. Genet Med 13 : 356-360, 2011
7) Williams JL, Williams MS : Informed consent and immunohistochemistry screening for Lynch syndrome. Genet Med 13 : 848-849, 2011
8) Beamer LC, Grant ML, Espenschied CR et al : Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 30 : 1058-1063, 2012
9) Kastrinos F, Syngal S : Screening patients with colorectal cancer for Lynch syndrome : What are we waiting for? J Clin Oncol 30 : 1024-1027, 2012
10) Pritchard CC, Smith C, Salipante SJ et al : ColoSeq provides comprehensive Lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 14 : 357-366, 2012
P.62 掲載の参考文献
11) Monteiro Santos EM, Valentin MD, Carneiro F et al : Predictive models for mutations in mismatch repair genes : implication for genetic counseling in developing countries. BMC Cancer 12 : 64, 2012
12) Kastrinos F, Steyerberg EW, Balmana J et al : Colon Cancer Family Registry : Comparison of the clinical prediction model PREMM1, 2, 6 and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut 62 : 272-279, 2013
13) Mercado RC, Hampel H, Kastrinos F et al : Colon Cancer Family Registry : Performance of PREMM1, 2, 6, MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med 14 : 670-680, 2012
14) Bessa X, Alenda C, Paya A et al : Validation microsatellite path score in a population-based cohort of patients with colorectal cancer. J Clin Oncol 29 : 3374-3380, 2011
P.63 掲載の参考文献
15) Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP et al : Quality of life after surgery for colon cancer in patients with Lynch syndrome : Partial versus subtotal colectomy. Dis Colon Rectum 55 : 653-659, 2012
16) Kalady MF, Lipman J, McGannon E et al : Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 255 : 1121-1125, 2012
17) Win AK, Lindor NM, Young JP et al : Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome. J Natl Cancer Inst 104 : 1363-1372, 2012
18) Pande M, Wei C, Chen J et al : Cancer spectrum in DNA mismatch repair gene mutation carriers : Results from a hospital based Lynch syndrome registry. Fam Cancer 11 : 441-447, 2012
P.64 掲載の参考文献
19) Grandval P, Baert-Desurmont S, Bonnet F et al : Colon-specific phenotype in Lynch syndrome associated with EPCAM deletion. Clin Genet 82 : 97-99, 2012
20) Huth C, Kloor M, Voigt AY et al : The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors. Mod Pathol 25 : 911-916, 2012
P.65 掲載の参考文献
21) Francisco I, Albuquerque C, Lage P et al : Familial colorectal cancer type X syndrome : two distinct molecular entities? Fam Cancer 10 : 623-631, 2011
22) Koh PK, Kalady M, Skacel M et al : Familial colorectal cancer type X : polyp burden and cancer risk stratification via a family history score. ANZ J Surg 81 : 537-542, 2011
23) Burn J, Gerdes AM, Macrae F et al ; CAPP2 Investigators : Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer : An analysis from the CAPP2 randomised controlled trial. Lancet 17 : 2081-2087, 2011
24) Chan AT, Lippman SM : Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet 378 : 2051-2052, 2011
25) Cleland JG : Does aspirin really reduce the risk of colon cancer? Lancet 379 : 1586-1587, 2012
P.66 掲載の参考文献
26) Kloor M, Huth C, Voigt AY et al : Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome : a pathological study. Lancet Oncol 13 : 598-606, 2012
27) Boland CR : Lynch syndrome : New tales from the crypt. Lancet Oncol 13 : 562-564, 2012
28) de Miranda NF, Goudkade D, Jordanova ES et al : Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases. Clin Cancer Res 18 : 1237-1245, 2012
29) Winkels RM, Botma A, Van Duijnhoven FJ et al : Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. Gastroenterology 142 : 241-247, 2012
P.67 掲載の参考文献
1) 矢野孝明, 野垣岳志, 浅野道雄 他 : 内痔核II度とIII度に対するALTA治療効果の比較検討. 臨床肛門病学 4 : 44-46, 2012
2) Infantino A, Altomare DF, Bottini C et al : Prospective randomized multicentre study comparing stapler haemorrhoidopexy with Doppler-guided transanal haemorrhoid dearterialization for third-degree haemorrhoids. Colorectal Dis 14 : 205-211, 2011
P.68 掲載の参考文献
3) Lewis R, Lunniss PJ, Hammond M : Novel biological strategies in the management of anal fistula. Colorectal Dis 14 : 1445-1455, 2012
4) Guadalajara H, Herreros D, De-La-Quintana P et al : Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 27 : 595-600, 2012
5) Sajid MS, Whitehouse PA, Sains P et al : Systematic review of the use of topical diltiazem compared with glyceryltrinitrate for the non-operative management of chronic anal fissure. Colorectal Dis (doi : 10.1111/j.1463-1318.2012.03042.x)
6) Yiannakopoulou E : Botulinum toxin and anal fissure : Efficacy and safety systematic review. Int J Colorectal Dis 27 : 1-9, 2012
7) Magdy A, El Nakeeb A, Fouda el Y et al : Comparative study of conventional lateral internal sphincterotomy, V-Y anoplasty, and tailored lateral internal sphincterotomy with V-Y anoplasty in the treatment of chronic anal fissure. J Gastrointest Surg 16 : 1955-1962, 2012
P.69 掲載の参考文献
8) Ersoz F, Arikan S, Sari S et al : Type of lateral internal sphincterotomy incision : Parallel or vertical? World J Surg 35 : 1137-1141, 2011
9) Gee T, Hisham RB, Jabar MF et al : Anococcygeal support in the treatment of idiopathic chronic posterior anal fissure : a prospective non-randomized controlled pilot study. Tech Coloproctol (doi 10.1007/s10151-012-0894-6)
10) 小出欣和, 前田耕太郎, 花井恒一 他 : 直腸脱に対する直腸固定術の手技と成績. 日本大腸肛門病会誌 65 : 840-846, 2012
11) Formijne Jonkers HA, Draaisma WA, Wexner SD et al : Evaluation and surgical treatment of rectal prolapse : an international survey. Colorectal Dis (doi : 10.1111/j.1463-1318.2012.03135.x)
12) Wong M, Meurette G, Abet E et al : Safety and efficacy of laparoscopic ventral mesh rectopexy for complex rectocele. Colorectal Dis 13 : 1019-1023, 2011
13) van der Hagen SJ, van Gemert WG, Soeters PB et al : Transvaginal posterior colporrhaphy combined with laparoscopic ventral mesh rectopexy for isolated Grade III rectocele : a prospective study of 27 patients. Colorectal Dis 14 : 1398-1402, 2012
P.70 掲載の参考文献
14) Brandner SB, Monga A, Mueller MD et al : Sexual function after rectocele repair. J Sex Med 8 : 583-588, 2011
15) 味村俊樹, 山名哲郎, 高尾良彦 他 : 本邦における便失禁診療の実態調査報告-診断と治療の現状. 日本大腸肛門病会誌 65 : 101-108, 2012
16) 味村俊樹, 山名哲郎, 高尾良彦 他 : 本邦における便失禁診療の実態調査報告-仙骨神経刺激療法の適応に関する検討-. 日本大腸肛門病会誌 65 : 109-117, 2012
17) Mellgren A, Wexner SD, Coller JA et al : Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 54 : 1065-1076, 2011
18) George AT, Kalmar K, Panarese A et al : Long-term outcomes of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 55 : 302-306, 2012
19) Giani L, Novelli E, Marina S et al : The effect of sacral nerve modulation on cerebral evoked potential latency in fecal incontinence and constipation. Ann Surg 254 : 90-96, 2011
P.71 掲載の参考文献
1) Forner A, Llovet JM, Bruix J : Hepatocellular carcinoma. Lancet 379 1245-1255, 2012
P.72 掲載の参考文献
2) Hosaka T, Suzuki F, Kobayashi M et al : Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology, 2012 (doi : 10.1002/hep.26180)
3) Izumi N, Asahina Y, Kurosaki M et al : Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C : a nationwide multicenter cooperative study. J Gastroenterol, 2012 (doi : 10.1007/s00535-012-0641-9)
4) Harada K, Hirohara J, Ueno Y et al : Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis : national data from Japan. Hepatology, 2012 (doi : 10.1002/hep.26176)
P.73 掲載の参考文献
5) Dohmen T, Kataoka E, Yamada I et al : Efficacy of contrast-enhanced ultra-sonography in radiofrequency ablation for hepatocellular carcinoma. Intern Med 51 : 1-7, 2012
6) Shindoh J, Andreou A, Aloia TA et al : Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm : reappraisal of the staging system for solitary tumors. Ann Surg Oncol, 2012 (doi : 10.1245/s10434-012-2739-y)
7) Adam R, Bhangui P, Vibert E et al : Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver. Does size define the best oncological strategy? Ann Surg 256 : 883-891, 2012
P.74 掲載の参考文献
8) Arii S, Sata M, Sakamoto M et al : Management of hepatocellular carcinoma : report of consensus meeting in the 45th annual meeting of the Japan Society of Hepatology 2009. Hepatol Res 40 : 667-685, 2010
9) 日本肝臓学会 編 : "科学的根拠に基づく肝癌診療ガイドライン 2009年版", 金原出版, 東京, 2009
10) Rahbari NN, Garden OJ, Padbury R et al : Posthepatectomy liver failure : a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149 : 713-724, 2011
11) Rahbari NN, Reissfelder C, Koch M et al : The predictive value of postoperative clinical risk scores for outcome after hepatic resection : a validation analysis in 807 patients. Ann Surg Oncol 18 : 3640-3649, 2011
12) Chen X, Zhai J, Cai X et al : Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg 99 : 1701-1710, 2012
P.75 掲載の参考文献
13) Yin Z, Fan X, Ye H et al : Short-and Long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma : a global systematic review and meta-analysis. Ann Surg Oncol, 2012 (doi : 10.1245/s10434-012-2705-8)
14) Shim JH, Han S, Lee YJ et al : Half-life of serum alpha-fetoprotein, an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma. Ann Surg, 2012 (doi : 10.1097/SLA.0b013e318273be70
P.76 掲載の参考文献
15) Schnitzbauer AA, Zuelke C, Graeb C et al : A prospective randomized, open-labeled, trial comparing sirolimus-containing versus mTOR inhibitor free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer 10 : 190, 2010
16) Duvoux C, Thoraval FR, Decaens T et al : Liver transplantation for hepatocellular carcinoma : a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology 143 : 986-994, 2012
P.77 掲載の参考文献
17) Burrel M, Reig M, Forner A et al : Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolization (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatology 56 : 1330-1335, 2012
18) Sato M, Tateishi R, Yasunaga H et al : Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma : a national survey of 54,145 patients. J Gastroenterol 47 : 1125-1133, 2012
P.78 掲載の参考文献
19) Bruix J, Raoul JL, Sherman M et al : Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma : subanalyses of a phase III trial. J Hepatol 57 : 821-829, 2012
P.79 掲載の参考文献
1) Palmer WC, Patel T : Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 57 : 69-76, 2012
2) Nordenstedt H, Mattsson F, El-Serag H et al : Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma. Br J Cancer 106 : 1011-1015, 2012
P.80 掲載の参考文献
3) Chong YS, Kim YK, Lee MW et al : Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. Clin Radiol 67 : 766-773, 2012
4) Park HJ, Kim YK, Park MJ et al : Small intrahepatic mass-forming cholangiocarcinoma : target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging, 2012 (doi : 10.1007/s00261-012-9943-x)
5) Igami T, Ebata T, Yokoyama Y et al : Staging of peripheral-type intrahepatic cholangiocarcinoma : appraisal of the new TNM classification and its modifications. World J Surg 35 : 2501-2509, 2011
6) Farges O, Fuks D, Regimbeau JM et al : Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma : a multicenter study by the AFC-IHCC-2009 study group. Ann Surg 254 : 824-829, 2011
7) Ribero D, Pinna AD, Guglielmi A et al : Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma : A Multi-Institutional Analysis of 434 Patients. Arch Surg 147 : 1107-1113, 2012
P.81 掲載の参考文献
8) Fisher SB, Patel SH, Kooby DA et al : Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma : a multi-institution analysis. HPB (Oxford) 14 : 514-522, 2012
9) Morine Y, Shimada M : Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 42 : 147-151, 2012
10) Chen TC, Jan YY, Yeh TS : K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol 19 : S675-681, 2012
11) Gu FM, Gao Q, Shi GM et al : Intratumoral IL-17+ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma. Ann Surg Oncol 19 : 2506-2514, 2012
12) Morine Y, Shimada M, Iwahashi S et al : Role of histone deacetylase expression in intrahepatic cholangiocarcinoma. Surgery 15 : 412-419, 2012
13) Higashi M, Yamada N, Yokoyama S et al : Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology 79 : 101-106, 2012
14) Eckmann KR, Patel DK, Landgraf A et al : Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma : a retrospective analysis. Gastrointest Cancer Res 4 : 155-160, 2011
P.82 掲載の参考文献
15) XuH X, Wang Y, LuM D et al : Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol 85 : 1078-1084, 2012
16) Vogl TJ, Naguib NN, Nour-Eldin NE et al : Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma : Results and prognostic factors governing treatment success. Int J Cancer 131 : 733-740, 2012
17) Halappa VG, Bonekamp S, Corona-Villalobos CP et al : Intrahepatic cholangiocarcinoma treated with local-regional therapy : quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology 264 : 285-294, 2012
18) Wu ZF, Zhang HB, Yang N et al : Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors : results of a large monocentric series. Eur J Surg Oncol 38 : 602-610, 2012
P.83 掲載の参考文献
1) Schnitzbauer AA, Lang SA, Goessmann H et al : Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255 : 405-414, 2012
P.84 掲載の参考文献
2) Tanaka K, Kumamoto T, Nojiri K et al : Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases. World J Surg 36 : 1832-1841, 2012
P.85 掲載の参考文献
3) Andres A, Toso C, Adam R et al : A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases : A LiverMetSurvey-Based Study. Ann Surg 256 : 772-779, 2012
P.86 掲載の参考文献
4) Spampinato MG, Mandala L, Quarta G et al : One-stage, totally laparoscopic major hepatectomy and colectomy for colorectal neoplasm with synchronous liver metastasis : Safety, feasibility and short-term outcome. Surgery, 2012 Jul 31 (doi : 10.1016/j.surg.2012.06.007)
P.87 掲載の参考文献
5) Di Fabio F, Whistance R, Rahman S et al : Exploring the role of laparoscopic surgery in two-stage hepatectomy for bilobar colorectal liver metastases. J Laparoendosc Adv Surg Tech A 22 : 647-650, 2012
6) Machado MA, Makdissi FF, Surjan RC : Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg ; 256 : e13 ; author reply e16-9, 2012
7) Chua TC, Saxena A, Liauw W et al : Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases--a systematic review. Eur J Cancer 48 : 1757-1765, 2012
P.88 掲載の参考文献
8) Weng M, Zhang Y, Zhou D et al : Radiofrequency ablation versus resection for colorectal cancer liver metastases : a meta-analysis. PLoS One 7 : e45493, 2012
P.89 掲載の参考文献
9) Gillams A, Khan Z, Osborn P et al : Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Intervent Radiol 2012 Oct 17 (doi : 10.1007/s00270-012-0500-3)
P.90 掲載の参考文献
11) Nordlinger B, et al : Peri-operative FOLFOX4 chemotherapy and surgery for resectable liver metastases from colorectal cancer : Long-term survival results of the EORTC intergroup phase III study 40983. 2012 ASCO Abstract #3508
12) Nanji S, Cleary S, Ryan P et al : Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol, 2012 Oct 5 (doi : 10.1245/s10434-012-2424-1)
13) Saiura A, Yamamoto J, Hasegawa K et al : Liver resection for multiple colorectal liver metastases with surgery up-front approach : bi-institutional analysis of 736 consecutive cases. World J Surg 36 : 2171-2178, 2012
14) Andreou A, Kopetz S, Maru DM et al : Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg 256 : 642-650, 2012
P.92 掲載の参考文献
1) 日本肝癌研究会 編 : "原発性肝癌取扱い規約, 第5版補訂版", 金原出版, 東京, 2009
2) 日本肝癌研究会 編 : "第18回全国原発性肝癌追跡調査報告 (2004~2005)", 2009
P.93 掲載の参考文献
3) 北井聡, 工藤正俊 : 混合型肝癌の疫学 : 全国集計を中心に. 肝胆膵 63 : 559-563, 2011
4) 有泉俊一, 山本雅一 : 混合型肝癌における予後と治療. 肝胆膵 63 : 593-600, 2011
5) Yin X, Zhang BH, Qiu SJ, et al : Combined hepatocellular carcinoma and cholangiocarcinoma : clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19 : 2869-2876, 2012
P.94 掲載の参考文献
6) 宇都宮徹, 島田光生, 居村暁 他 : 原発性肝肉腫. 日本臨牀 (別冊 新領域別症候群シリーズ 肝・胆道系症候群 II), pp276-280, 2010
7) 上村顕也, 須田剛士, 青柳豊 : 肝類上皮血管内皮腫. 日本臨牀 (別冊 新領域別症候群シリーズ 肝・胆道系症候群 II), pp225-228, 2010
8) 山崎香奈, 趙成済, 桑鶴良平 : 類上皮性血管内皮腫epithelioid hemangioendotheliomaと肝表面の陥凹. 画像診断 32 : 94-95, 2012
9) Wang LR, Zhou JM, Zhao YM et al : Clinical experience with primary hepatic epithelioid hemangioendothelioma : Retrospective study of 33 patients. World J Surg 36 : 2677-2683, 2012
P.95 掲載の参考文献
10) 三浦智史, 高橋達 : 肝血管肉腫. 日本臨牀 (別冊 新領域別症候群シリーズ 肝・胆道系症候群 II), pp283-286, 2010
11) 須納瀬豊, 平井圭太郎, 吉成大介 他 : 急性の肝破裂に対して緊急肝切除により救命しえた肝未分化肉腫の1例. 手術 65 : 381-384, 2011
12) 龍知記, 高見裕子, 立石昌樹 他 : 術後4年以上生存中の成人肝未分化肉腫の1例. 日本消化器外科学会雑誌 45 : 273-281, 2012
13) Noguchi K, Yokoo H, Nakanishi K et al : A long-term survival case of adult undifferentiated embryonal sarcoma of liver. World J Surg Oncol 2012 Apr 27 ; 10 : 65 (doi : 10.1186/1477-7819-10-65)
P.96 掲載の参考文献
14) 日本小児外科学会悪性腫瘍委員会 : 小児の外科的悪性腫瘍. 2010年登録症例の全国集計結果の報告. 日小外会誌 48 : 92-129, 2012
15) Hishiki T, Matsunaga T, Sasaki F et al : Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2 : Report from the JPLT. Pediatr Surg Int 27 : 1-8, 2011
P.97 掲載の参考文献
16) Wang YX, Liu H : Adult hepatoblastoma : Systemic review of the English literature. Dig Surg 29 : 323-330, 2012
17) 中島収 : 新WHO分類による肝細胞腺腫の位置づけと亜分類. 病理と臨床 30 : 230-231, 2012
18) Sasaki M, Nakanuma Y : Overview of hepatocellular adenoma in Japan. Int J Hepatol, 2012 (doi : 10.1155/2012/648131)
P.98 掲載の参考文献
P.99 掲載の参考文献
P.100 掲載の参考文献
P.101 掲載の参考文献
1) 市田隆文, 玄田拓哉 : 治療の最新情報HBVに対する最新の肝移植事情 肝移植後のHBV再感染とde novo肝炎に対する対応. 医学のあゆみ 242 : 455-459, 2012
P.102 掲載の参考文献
P.103 掲載の参考文献
P.104 掲載の参考文献
P.105 掲載の参考文献
P.106 掲載の参考文献
P.107 掲載の参考文献
P.108 掲載の参考文献
1) 和久井紀貴, 高山竜司, 金川武徳 他 : 門脈圧亢進症の血行動態診断におけるParametric Imagingの有用性について. 日本門脈圧亢進症学会雑誌 18 (1) : 14-18, 2012
P.109 掲載の参考文献
P.110 掲載の参考文献
P.111 掲載の参考文献
P.112 掲載の参考文献
P.113 掲載の参考文献
22) 田尻和人, 河合健吾, 時光善温 他 : 脾摘術を施行しインターフェロンを導入したC型肝硬変7症例の検討. 日本門脈圧亢進症学会雑誌 18 (1) : 40-44, 2012
P.114 掲載の参考文献
1) 厚生労働省 : 印刷業等の洗浄作業における有機塩素系洗浄剤のばく露低減化のための予防的取組みについて. 平成24年7月23日付基安発0723 第1号
P.115 掲載の参考文献
P.116 掲載の参考文献
P.117 掲載の参考文献
P.118 掲載の参考文献
P.119 掲載の参考文献
P.120 掲載の参考文献
22) Croitoru A, Gramaticu I, Dinu I et al : Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma-a retrospective study. J Gastrointestin Liver Dis 21 : 277-284, 2012
23) Katayose Y, Ohtsuka H, Kitamura Y et al : An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer. Hepatogastroenterology 59 : 691-695, 2012
P.121 掲載の参考文献
P.122 掲載の参考文献
P.123 掲載の参考文献
P.124 掲載の参考文献
P.125 掲載の参考文献
10) 石原慎, 宮川秀一, 堀口明彦 他 : 開腹胆嚢摘出術および胆嚢癌症例におけるIncidental Gallbladder Cancerの頻度. 胆と膵 32 (5) : 379-383, 2011
11) 胆道癌診療ガイドライン作成出版委員会 編 : "エビデンスに基づいた胆道癌診療ガイドライン", 医学図書出版, 2007
P.126 掲載の参考文献
P.127 掲載の参考文献
P.128 掲載の参考文献
P.129 掲載の参考文献
P.130 掲載の参考文献
P.131 掲載の参考文献
P.132 掲載の参考文献
P.133 掲載の参考文献
P.134 掲載の参考文献
1) 武田和憲, 片岡慶正, 木原康之, 他 : 急性膵炎重症度判定基準の改定とガイドライン 2010. 日本腹部救急医学会雑誌 31 (3) : 523-528, 2011
2) 急性膵炎診療ガイドライン2010改訂出版委員会 編 : "急性膵炎診療ガイドライン2010 [第3版]", 金原出版, 2009
P.135 掲載の参考文献
P.136 掲載の参考文献
P.137 掲載の参考文献
20) 厚生労働省難治性膵疾患に関する調査研究班, 日本膵臓学会, 日本消化器病学会 : 慢性膵炎臨床診断基準 2009. 膵臓 24 : 645-646, 2009
21) 日本消化器病学会 編 : "慢性膵炎診療ガイドライン", 南江堂, 2009
P.138 掲載の参考文献
P.139 掲載の参考文献
P.140 掲載の参考文献
2) National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma. Version 2. 2012
3) 蒲田敏文, 龍泰治, 南哲弥 他 : 膵癌におけるDynamic CT撮像方法と脈管浸潤. 胆と膵 32 : 585-592, 2011
4) 北川裕久, 蒲田敏文, 大坪公士郎 : 画像と病理の対比から学ぶ膵癌診療アトラス. 学研メディカル秀潤社, 2012
5) 北川裕久, 田島秀浩, 中川原寿俊 他 : Borderline Resectable膵頭部癌の診断と治療成績. 胆と膵 32 : 609-614, 2011
P.141 掲載の参考文献
P.142 掲載の参考文献
16) Makino I, Kitagawa H, Ohta T et al : The management of a remnant pancreatic stump for preventing the development of postoperative pancreatic fistulas after distal pancreatectomy : current evidence and our strategy. Surg Today, 2012 (doi : 10.1007/s00595-012-0370-y)
P.143 掲載の参考文献
19) 大東弘明, 高橋秀典, 石川治 : 膵癌に対する術前化学療法. 日消誌 108 : 1646-1653, 2011
P.144 掲載の参考文献
28) Conroy T, Desseigne F, Ychou M et al : FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364 : 1817-1825, 2011
P.145 掲載の参考文献
30) Miyazawa M, Yamaue H : The development of a novel cancer vaccine using Peptide vaccine for patients with advanced pancreatic cancer. Gan To Kagaku Ryoho 38 : 1903-1905, 2011
P.146 掲載の参考文献
P.148 掲載の参考文献
P.149 掲載の参考文献
P.150 掲載の参考文献
P.151 掲載の参考文献
P.152 掲載の参考文献
P.153 掲載の参考文献
P.154 掲載の参考文献
P.155 掲載の参考文献
P.156 掲載の参考文献
P.157 掲載の参考文献
P.158 掲載の参考文献
P.159 掲載の参考文献
P.160 掲載の参考文献
P.161 掲載の参考文献
P.162 掲載の参考文献
P.163 掲載の参考文献
P.164 掲載の参考文献
P.165 掲載の参考文献
P.166 掲載の参考文献
P.167 掲載の参考文献
P.168 掲載の参考文献
P.170 掲載の参考文献
7) Perez EA, Piper H, Burkhalter LS et al : Single-incision laparoscopic surgery in children : a randomized control trial of acute appendicitis. Surg Endosc, 2012 (10.1007/s00464-012-2617-5)
P.171 掲載の参考文献
11) Fuentes MB, Goel R, Lee-Ong AC et al : Single-port endo-laparoscopic surgery (SPES) for totally extraperitoneal inguinal hernia : a critical appraisal of the chopstick repair. Hernia, 2012 (doi : 10.1007/s10029-012-0968-4)
P.172 掲載の参考文献
27) Kodera Y : Reduced port surgery for gastric cancer : another giant leap for mankind? Gastric Cancer, 2012 (doi : 10.1007/s10120-012-0221-y)
28) Kawamura H, Tanioka T, Kuji M et al : The initial experience of dual port laparoscopy-assisted total gastrectomy as a reduced port surgery for total gastrectomy. Gastric Cancer, 2012 (doi : 10.1007/s10120-012-0212-z)
29) Lim SW, Kim HJ, Kim CH et al : Umbilical incision laparoscopic colectomy with one additional port for colorectal cancer. Tech Coloproctol, 2012 (doi : 10.1007/s10151-012-0900-z)
P.173 掲載の参考文献
P.175 掲載の参考文献
P.176 掲載の参考文献
4) Hansen C, Black D, Lange C et al : Auditory support for resection guidance in navigated liver surgery. Int J Med Robot, 2012 (doi : 10.1002/rcs.1466)
P.177 掲載の参考文献
8) Onda S, Okamoto T, Kanehira M et al : Short rigid scope and stereo-scope designed specifically for open abdominal navigation surgery : clinical application for hepatobiliary and pancreatic surgery. J Hepatobiliary Pancreat Sci, 2012 (doi : 10.1007/s00534-012-0582-y)
10) 草野満夫 編 : "ICG蛍光Navigation Surgeryのすべて", インターメディカ社, 東京, 2008
11) 河地茂行, 田邉 稔, 篠田昌宏, 他 : 肝区域のTattooingと腫瘍のMarking-胆嚢癌の至適肝切除範囲の同定LED 励起ICG蛍光により同定した胆嚢静脈灌流域を切除する胆嚢癌に対する拡大胆嚢摘出術の1例. "ICG蛍光Navigation Surgeryのすべて" (草野満夫 編), インターメディカ, 東京, pp349-354, 2008
12) 多賀谷信美, 阿部曉人, 窪田敬一 : ICG術中蛍光胆道検索を併用した単孔式腹腔鏡下胆嚢摘出術-手術手技のコツおよび非併用例との比較-. 胆道 25 (4) : 619-625, 2011
P.178 掲載の参考文献
14) 二村浩史, 高橋直人, 渡部篤史 他 : 赤外線腹腔鏡システムを用いたテーラーメイド胃癌治療. リンパ学 32 (2) : 91-96, 2009
16) 杉本健樹, 花崎和弘, 佐藤隆幸 : Hyper Eye Medical Systemを用いた乳癌センチネルリンパ節生検手技. 手術 65 : 421-425, 2011
17) 中村哲也, 吉田昌, 北島政樹 他 : ハイパーアイメディカルシステム (Hyper Eye Medical System ; HEMS) の腹部外科への応用. Prog Med 31 : 806-809, 2011
P.179 掲載の参考文献
P.180 掲載の参考文献
P.181 掲載の参考文献
P.182 掲載の参考文献
P.183 掲載の参考文献
P.184 掲載の参考文献
24) Montemurro M, Gelderblom H, Bitz U et al : Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib : A retrospective analysis. Eur J Cancer, 2012 (doi : 10.1016/j.ejca.2012.10.009)
P.185 掲載の参考文献
P.186 掲載の参考文献
1) 北野正剛, 山下裕一, 白石憲男 他 : 内視鏡外科手術に関するアンケート調査-第11回集計結果報告 (日本内視鏡外科学会). 日本内視鏡外科学会雑誌 17 (5) : 571-694, 2012
2) 北野正剛, 山下裕一, 白石憲男 他 : 日本内視鏡外科学会 内視鏡外科手術に関するアンケート調査 第10回集計結果報告. 日本内視鏡外科学会雑誌 15 (5) : 565-679, 2010
P.187 掲載の参考文献
P.188 掲載の参考文献
P.189 掲載の参考文献
16) Yokoe M, Takada T, Strasberg SM et al : TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 20 : 35-46, 2013
21) 山下裕一, 乗富智明, 松岡信秀 他 : 【急性胆管炎・胆嚢炎の診療ガイドラインを検証する-改訂に向けてのプロセスと課題-】急性胆嚢炎に対する腹腔鏡下胆嚢摘出術は推奨治療になったか. 日本腹部救急医学会雑誌 32 (3) : 651-656, 2012
P.190 掲載の参考文献
23) Nakamura M, Nakashima H : Laparoscopic distal pancreatectomy and pancreatoduodenectomy : is it worthwhile? A meta-analysis of laparoscopic pancreatectomy. J Hepatobiliary Pancreat Sci, 2012 (doi : 10.0007/s00534-012-0578-7)
25) 山口幸二, 皆川紀剛 : 日本膵臓学会膵癌診療ガイドライン改訂委員会 膵癌診療の最近の動向とガイドライン改訂に向けて "Annual review 消化器 2012", 中外医学社, pp242-247, 2012
P.191 掲載の参考文献

II章

P.196 掲載の参考文献
2) Fu L, Zhang C, Zhang LY et al : Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway. Gut 60 : 1635-1643, 2011
4) Tenbaum SP, Ordonez-Moran P, Puig I et al : β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 18 : 892-901, 2012
P.197 掲載の参考文献
P.198 掲載の参考文献
P.199 掲載の参考文献
P.200 掲載の参考文献
P.202 掲載の参考文献
P.203 掲載の参考文献
P.204 掲載の参考文献
P.205 掲載の参考文献
P.206 掲載の参考文献
25) Agarwal A, Polineni R, Hussein Z et al : Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol 5 (5) : 382-396, 2012
26) Podolska K, Stachurska A, Hajdukiewicz K et al : Gene therapy prospects--intranasal delivery of therapeutic genes. Adv Clin Exp Med 21 (4) : 525-534, 2012
P.207 掲載の参考文献
P.208 掲載の参考文献
P.209 掲載の参考文献
P.210 掲載の参考文献
P.211 掲載の参考文献
13) "胃癌治療ガイドライン速報 (2012年11月)" http://www.jgca.jp/pdf/GL201211.pdf
P.212 掲載の参考文献
P.213 掲載の参考文献
P.214 掲載の参考文献
P.215 掲載の参考文献
1) 日本肝臓学会 編 : "科学的根拠に基づく肝癌診療ガイドライン (2009年版)", 金原出版, 東京, 2009
P.216 掲載の参考文献
P.217 掲載の参考文献
P.218 掲載の参考文献
18) 日本膵臓学会膵癌診療ガイドライン改訂委員会 編 : "科学的根拠に基づく膵癌診療ガイドライン (2009年版)", 金原出版, 東京, 2009
P.219 掲載の参考文献
P.220 掲載の参考文献
26) NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network, pancreatic adenocarcinoma http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
P.222 掲載の参考文献
P.223 掲載の参考文献
10) 鍋谷圭宏 : 【病態別経腸栄養法~病態別経腸栄養剤をいかに選択し, いかに使用するか? ~】エビデンスに基づく病態別経腸栄養法 病態別経腸栄養剤の選び方と使い方-周術期. 静脈経腸栄養 27 (2) : 643-650, 2012
11) 古川勝, 鈴木大, 相田俊 他 : 【肝胆膵疾患と栄養療法の最前線】胆道, 膵疾患と栄養 膵頭十二指腸切除術におけるimmunonutrition. 肝胆膵 63 (3) : 517-523, 2011
P.224 掲載の参考文献
P.225 掲載の参考文献
P.226 掲載の参考文献
P.227 掲載の参考文献
P.228 掲載の参考文献
P.229 掲載の参考文献
P.230 掲載の参考文献
P.231 掲載の参考文献
P.232 掲載の参考文献
P.234 掲載の参考文献
2) Dudley ME, Gross CA, Somerville RP et al : Randomized Selection Design Trial Evaluating CD8+ -Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma. J Clin Oncol 2013 (doi : 10.1200/JCO.2012.46.6441)
P.235 掲載の参考文献
P.236 掲載の参考文献
P.237 掲載の参考文献
P.238 掲載の参考文献
P.239 掲載の参考文献
P.240 掲載の参考文献
P.241 掲載の参考文献
P.242 掲載の参考文献
P.243 掲載の参考文献
P.244 掲載の参考文献
P.245 掲載の参考文献
7) Kim YK, Lee MW, Lee WJ et al : Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acidenhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≦ 1.5 cm in diameter). Invest Radiol 47 (3) : 159-166, 2012
P.246 掲載の参考文献
P.247 掲載の参考文献
P.248 掲載の参考文献

最近チェックした商品履歴

Loading...